Hyep Ivan
SEC insider (Form 3/4/5 filer). CIK 0002034668. Chief Financial Officer at Bicara Therapeutics Inc. (BCAX). 34 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in BOSTON, MA.
Companies Hyep Ivan has filed insider reports for
- Bicara Therapeutics Inc. (BCAX): Officer, Chief Financial Officer
Hyep Ivan
CIK: 0002034668
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bicara Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Aug 10, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect12.5K shares at avg. $3.79$47K - Aug 10, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect12.5K shares at avg. $27.97$350K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect12.5K shares at avg. $3.79$47K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect22.8K shares at avg. $28.60$651K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect4.4K shares at avg. $29.82$132K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect830 shares at avg. $30.31$25K - May 21, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect9.2K shares at avg. $20.42$188K - May 21, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect9.2K shares at avg. $3.79$35K - Apr 21, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect9.2K shares at avg. $23.00$212K - Apr 21, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect9.2K shares at avg. $3.79$35K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 12,500 | $3.79 | $47,373 | Direct |
| Aug 10, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 12,500 | $27.97 | $349,591 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 12,500 | $3.79 | $47,373 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 22,757 | $28.60 | $650,896 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 4,413 | $29.82 | $131,616 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 830 | $30.31 | $25,160 | Direct |
| May 21, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 9,200 | $20.42 | $187,883 | Direct |
| May 21, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 9,200 | $3.79 | $34,866 | Direct |
| Apr 21, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 9,200 | $23.00 | $211,614 | Direct |
| Apr 21, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 9,200 | $3.79 | $34,866 | Direct |
1-10 of 34 transactions